Miyake Y, Tajima S, Yamamura T, Yamamoto A
Proc Natl Acad Sci U S A. 1981 Aug;78(8):5151-5. doi: 10.1073/pnas.78.8.5151.
During studies on binding of low density lipoprotein (LDL) to fibroblasts from patients with the homozygous form of familial hypercholesterolemia (FH), a unique line was derived from subject M.N. This line could bind as much LDL as normal cells, or even more. However, like fibroblasts from other patients with the homozygous form of FH, it failed to show regulation of cholesterol synthesis. Analyses of the LDL receptors showed that this line could not mediate internalization of receptor-bound LDL. Studies on the fibroblasts of the parents of this subject showed that the inability to internalize LDL was hereditary and that the subject was a pure homozygote for this defect. The plausibility of this finding was supported by the fact that her parents were first cousins. The possible existence of a homozygous state of this defect was predicted by Goldstein et al. [Goldstein, J. L., Brown, M. S. & Stone, N. J. (1977) Cell 12, 629-41], but an actual case of the internalization defect in a pure homozygous form had not been found. There were no differences from normal cells in the nature of the LDL binding activity of this line, such as in its specificity, affinity, or Ca2+ requirement.
在对家族性高胆固醇血症(FH)纯合子患者的成纤维细胞进行低密度脂蛋白(LDL)结合研究期间,从受试者M.N.获得了一个独特的细胞系。该细胞系结合的LDL量与正常细胞相同,甚至更多。然而,与其他FH纯合子患者的成纤维细胞一样,它未能显示出胆固醇合成的调节。对LDL受体的分析表明,该细胞系不能介导受体结合的LDL的内化。对该受试者父母的成纤维细胞研究表明,LDL内化能力的缺失具有遗传性,且该受试者是这种缺陷的纯合子。她的父母是近亲这一事实支持了这一发现的合理性。Goldstein等人[Goldstein, J. L., Brown, M. S. & Stone, N. J. (1977) Cell 12, 629 - 41]预测了这种缺陷纯合状态的可能存在,但尚未发现纯合形式的内化缺陷的实际病例。该细胞系LDL结合活性的性质与正常细胞没有差异,如特异性、亲和力或对Ca2+的需求。